| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.1 | 0.1 |
| Net income | -1.5 | -1.7 |
| EPS (diluted, $ a share) | $-0.08 | $-0.10 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +17.9% |
|---|
10-Q filed with the SEC, OTC: HRGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Harvard Apparatus Regenerative Technology, Inc.: key numbers
- Share price
- $1.90Close, Nov 16
- Market cap
- $38.2M
- Shares outstanding
- 20.09MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Harvard Apparatus Regenerative Technology, Inc.
All →Harvard Apparatus Regenerative Technology CEO Junli He Buys $394K of Stock
Junli He, CEO, bought 368,630 shares of Harvard Apparatus Regenerative Technology, Inc. at $1.05 to $2.15 a share (average $1.07) in 2 transactions, worth $394K in total between Sep 11, 2026 and Sep 15, 2026. Shares held after the trade: 1,332,930 (+0.5%).
- Value
- $394K
- Shares
- 368,630
- Average price
- $1.07
- Role
- CEO
- Holding change
- +0.5%
- Trade date
- Sep 11, 2026 to Sep 15, 2026
Harvard Apparatus Regenerative Technology Capital Raise of $2.84M
Harvard Apparatus Regenerative Technology closed a private placement of 2,703,727 shares of common stock at $1.05 per share for total proceeds of approximately $2.84 million. The transaction included a $717,911 debt-for-equity conversion by CEO Jerry (Junli) He, who cancelled outstanding bridge promissory notes in exchange for shares at the same offering price.
- Value
- $2.84M
- Counterparty
- Jerry (Junli) He and other private investors